CELLULARLINE SPA (CELL.MI) Forecast, Price Target & Analyst Ratings
BIT:CELL • IT0005244618
2.42 EUR
-0.02 (-0.82%)
Last: Mar 11, 2026, 02:16 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLULARLINE SPA (CELL.MI).
Forecast Snapshot
Consensus Price Target
€4.18
+ 72.81% Upside
Next Earnings Forecast
Release DateMar 9, 2026
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€4.18
Upside
+ 72.81%
From current price of €2.42 to mean target of €4.18, Based on 7 analyst forecasts
Low
€4.14
Median
€4.18
High
€4.31
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for CELL.MI. The average price target is 4.18 EUR. This implies a price increase of 72.81% is expected in the next year compared to the current price of 2.42.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
CELL.MI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CELL.MI.
In the previous month the buy percentage consensus was at a similar level.
CELL.MI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 9, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 137.644M 24.48% | 158.648M 15.26% | 164.263M 3.54% | 159.83M -2.70% | 168.3M 5.30% | |
| EBITDA YoY % growth | 87.321M 312.03% | 18.47M -78.85% | 21.79M 17.98% | 22.052M 1.20% | 24.409M 10.69% | |
| EBIT YoY % growth | -749K -133.97% | 5.065M 776.23% | 8.066M 59.25% | 14.708M 82.35% | 16.759M 13.94% | |
| Operating Margin | -0.54% | 3.19% | 4.91% | 9.20% | 9.96% | |
| EPS YoY % growth | N/A 28.17% | N/A -25.20% | N/A 4.17% | 0.35 -15.00% | 0.43 23.53% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CELLULARLINE SPA / CELL.MI Forecast FAQ
What is the price target for CELL stock?
7 analysts have analysed CELL.MI and the average price target is 4.18 EUR. This implies a price increase of 72.81% is expected in the next year compared to the current price of 2.42.
What is the next earnings date for CELL stock?
CELLULARLINE SPA (CELL.MI) will report earnings on 2026-03-09.